Category: Pharmaceuticals
Pharmaceuticals market research reports by The Insight Partners
-
Anti-obesity Drugs Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Prescription and OTC ), Drug Class (GLP-1 Agonist, Lipase Inhibitors, MC4R agonist, and others), Application (Appetite Suppression, Inhibition of Fat Absorption/Digestive Enzymes, Metabolic Enhancement, and Combination), Route of Administration (Oral and Parenteral), and Distribution Channel (Hospital Pharmacies, Online Channel, and Retail Pharmacies), and Geography
According to our new research study on “Anti-obesity Drugs Market Forecast to 2031 –Global Analysis – by Type, Drug Class, Route of Administration, Application, Distribution Channel, and Geography,” the market is anticipated to grow from US$ 15.85 billion in 2024 and is projected to reach US$ 177.27 ... Read More
-
DNA Plasmid Manufacturing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (GMP Grade and R&D grade), Application (Cell and Gene Therapy, DNA Vaccines, Immunotherapy, and Others), End User (Pharmaceutical and Biotechnology Companies, CROs and CDMOs, and Others) and Geography
The DNA plasmid Manufacturing Market is expected to reach US$ 2,648.36 Mn by 2031 from US$ 686.38 Mn in 2024; the market is estimated to grow at a CAGR of 21.4% during 2025–2031. Major factors driving the market growth include increasing plasmid developments for gene therapy and growing research on ... Read More
-
Biopharmaceutical Contract Manufacturing Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Biologics and Biosimilar), Source (Microbial and Mammalian), Application (Commercial and Clinical), Therapeutic Area (Oncology, Autoimmune Disorders, Respiratory Disorders, Metabolic Disorders, Neurology, Infectious Diseases, and Others), and Geography
The biopharmaceutical contract manufacturing market size is expected to grow from US$ 40.99 billion in 2024 to US$ 101.05 billion by 2031; it is projected to register a CAGR of 13.8% during 2025-2031. Rising demand for biologics and increasing demand for cost efficiency and flexibility are noteworth ... Read More
-
Africa Anticancer Drugs Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, Immunotherapy Drugs, Gene Therapy Drugs, Radiopharmaceuticals, and Others), Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostrate Cancer, and Others), Dosage Form (Tablet and Capsule, Injectable, and Liquid), Therapy (Chemotherapy, Targeted Therapy, Immunotherapy, Gene Therapy, Radiopharmaceutical Therapy, and Others), Sector (Private and Public), and Country
The Africa anticancer drugs market is expected to reach US$ 3.23 billion by 2031 from US$ 1.81 billion in 2024. The market is estimated to grow with a CAGR of 8.8% from 2025 to 2031. The Africa anticancer drugs market forecast presented in this report can help stakeholders in this marketplace plan t ... Read More
-
Cell and Gene Therapy Contract Development and Manufacturing Organization Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography
According to our new research study on “Cell and Gene Therapy Contract Development and Manufacturing Organization Market Forecast to 2031 –Global Analysis – by Service Type, Product Type, End User, and Geography,” the market is anticipated to grow from US$ 6.22 billion in 2024 and is projected to re ... Read More
-
Contract Research Organization Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Early Phase Development Services, Clinical Research Services, Laboratory Services, and Post-Approval Services), Product Type (Cell and Gene Therapy, Biosimilars, Antibody Drug Conjugates, and Others), Type (In-house and Outsource), Application (Oncology, Neurology, Cardiology, Infectious Diseases, Metabolic Disorder, Nephrology, Respiratory, Dermatology, Ophthalmology, Hematology, and Others), End User (Pharmaceutical and Biotech Companies, Medical Device Companies, Academic and Research Institutes, and Others) and Geography
The contract research organization market is expected to reach US$ 113.79 billion by 2031 from US$ 65.38 billion in 2024; the market is estimated to grow at a CAGR of 8.2% during 2025–2031. Major factors driving the market growth include increased outsourcing of R&D and rising demand for clinical tr ... Read More
-
North America Transient Protein Expression Market Forecast to 2031 - Regional Analysis - by Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
The North America transient protein expression market was valued at US$ 324.14 million in 2023 and is expected to reach US$ 518.73 million by 2031; it is estimated to register a CAGR of 6.1% from 2023 to 2031. Surging Popularity of Precision Medicine Fuels North America Transient Protein Expression ... Read More
-
North America Liquid Nitrogen Market Forecast to 2031 - Regional Analysis - by Manufacturing Method (Cryogenic Distillation and Pressure Swing Adsorption) and End-use Industry (Aerospace and Defense, Automotive, Chemical, Food and Beverage, Metal Fabrication, Pharmaceutical, Electronics and Semiconductors, and Others)
The North America liquid nitrogen market was valued at US$ 4,022.18 million in 2023 and is expected to reach US$ 6,102.70 million by 2031; it is estimated to register a CAGR of 5.3% from 2023 to 2031. Increasing Use of Liquid Nitrogen in Pharmaceutical Industry Fuels North America Liquid Nitrogen Ma ... Read More
-
South & Central America Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis - by Product (Noninvasive Ventilation Disposable Mask and Noninvasive Ventilation Reusable Mask), Application (Sleep Apnea, Chronic Obstructive Pulmonary Disease, Pneumonia, and Others), and End User (Hospitals and Clinics, Home Care, and Others)
The South & Central America non-invasive ventilation masks market was valued at US$ 80.24 million in 2023 and is expected to reach US$ 115.12 million by 2031; it is estimated to register a CAGR of 4.6% from 2023 to 2031. Increasing Adoption of NIV Masks Fuels South & Central America Non-Invasive Ven ... Read More
-
South & Central America Transient Protein Expression Market Forecast to 2031 - Regional Analysis - by Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
The South & Central America transient protein expression market was valued at US$ 43.70 million in 2023 and is expected to reach US$ 64.23 million by 2031; it is estimated to register a CAGR of 4.9% from 2023 to 2031. Increasing Applications of Protein Expression Systems Fuel South & Central America ... Read More
-
Middle East & Africa Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 - Regional Analysis - by Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others]
The Middle East & Africa electronic patient-reported outcomes (ePROS) market was valued at US$ 23.79 million in 2023 and is expected to reach US$ 60.23 million by 2031; it is estimated to register a CAGR of 12.3% from 2023 to 2031. Integration of Artificial Intelligence and Machine Learning with ePR ... Read More
-
Middle East & Africa Traumatic Brain Injury Diagnostics Equipment Market Forecast to 2030 - Regional Analysis - by Techniques (Non-Invasive, Invasive, and Combination Techniques), Device (Imaging devices and Monitoring Devices), and End User (Hospitals and Clinics, Diagnostic Centers, and Others)
The Middle East & Africa traumatic brain injury diagnostics equipment market was valued at US$ 82.73 million in 2022 and is expected to reach US$ 149.57 million by 2030; it is estimated to register a CAGR of 7.7% from 2022 to 2030. Emergence of Portable Non-invasive Monitoring Devices to Diagnose TB ... Read More
-
Asia Pacific Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), and End User (Hospitals, Dermatology Centers, and Others)
The Asia Pacific hyperpigmentation disorder treatment market was valued at US$ 2,462.36 million in 2022 and is expected to reach US$ 4,468.99 million by 2030; it is estimated to register a CAGR of 7.7% from 2022 to 2030. Strategic Initiatives by Market Players Boost Asia Pacific Hyperpigmentation Di ... Read More
-
Asia Pacific Traumatic Brain Injury Diagnostics Equipment Market Forecast to 2030 - Regional Analysis - by Techniques (Non-Invasive, Invasive, and Combination Techniques), Device (Imaging devices and Monitoring Devices), and End User (Hospitals and Clinics, Diagnostic Centers, and Others)
The Asia Pacific traumatic brain injury diagnostics equipment market was valued at US$ 362.82 million in 2022 and is expected to reach US$ 1,030.47 million by 2030; it is estimated to register a CAGR of 13.9% from 2022 to 2030. Growing Use of MRI over CT to Limit Inpatient Mortality and Marginally R ... Read More
-
Asia Pacific Transient Protein Expression Market Forecast to 2031 - Regional Analysis - by Product Type (Instruments, Reagents, Expression Vectors, and Competent Cells), Application (Genomic Research, Gene Therapy, Bio production, Cancer Research, and Drug Development), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
The Asia Pacific transient protein expression market was valued at US$ 181.05 million in 2023 and is expected to reach US$ 294.26 million by 2031; it is estimated to register a CAGR of 6.3% from 2023 to 2031. Plant-Based Expression Systems for Therapeutic Protein Production Boost Asia Pacific Transi ... Read More
-
North America Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis - by Product (Noninvasive Ventilation Disposable Mask and Noninvasive Ventilation Reusable Mask), Application (Sleep Apnea, Chronic Obstructive Pulmonary Disease, Pneumonia, and Others), and End User (Hospitals and Clinics, Home Care, and Others)
The North America non-invasive ventilation masks market was valued at US$ 902.92 million in 2023 and is expected to reach US$ 1,412.14 million by 2031; it is estimated to register a CAGR of 5.7% from 2023 to 2031. Increasing Prevalence of Respiratory Diseases Fuels North America Cosmetic Preservativ ... Read More
-
South & Central America Electronic Patient-Reported Outcomes (ePROS) Market Forecast to 2031 - Regional Analysis - by Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others]
The South & Central America electronic patient-reported outcomes (ePROS) market was valued at US$ 32.06 million in 2023 and is expected to reach US$ 86.04 million by 2031; it is estimated to register a CAGR of 13.1% from 2023 to 2031. Rising Adoption of Telehealth and Remote Monitoring Fuels South & ... Read More
-
Europe Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis - by Product (Noninvasive Ventilation Disposable Mask and Noninvasive Ventilation Reusable Mask), Application (Sleep Apnea, Chronic Obstructive Pulmonary Disease, Pneumonia, and Others), and End User (Hospitals and Clinics, Home Care, and Others)
The Europe non-invasive ventilation masks market was valued at US$ 574.58 million in 2023 and is expected to reach US$ 922.02 million by 2031; it is estimated to register a CAGR of 6.1% from 2023 to 2031. Growing Inclination Towards Home Healthcare Drive Europe Cosmetic Preservatives Market A shift ... Read More
-
North America Traumatic Brain Injury Diagnostics Equipment Market Forecast to 2030 - Regional Analysis - by Techniques (Non-Invasive, Invasive, and Combination Techniques), Device (Imaging devices and Monitoring Devices), and End User (Hospitals and Clinics, Diagnostic Centers, and Others)
The North America traumatic brain injury diagnostics equipment market was valued at US$ 1,360.02 million in 2022 and is expected to reach US$ 3,340.17 million by 2030; it is estimated to register a CAGR of 11.9% from 2022 to 2030. Accelerated Demand for Advanced Diagnostic Equipment Fuels North Amer ... Read More
-
North America Neurorehabilitation Devices Market Forecast to 2031 - Regional Analysis - by Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson's Disease, Cerebral Palsy, and Others), and End User (Rehabilitation Centers, Hospitals and Clinics, and Home Care)
The North America neurorehabilitation devices market was valued at US$ 1,512.12 million in 2023 and is expected to reach US$ 3,891.70 million by 2031; it is estimated to register a CAGR of 12.5% from 2023 to 2031. Increasing Prevalence of Neurological Diseases Fuels North America Neurorehabilitation ... Read More
-
Asia Pacific Neurorehabilitation Devices Market Forecast to 2031- Regional Analysis - by Product Type (Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, and Wearable Devices), Application (Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson's Disease, Cerebral Palsy, and Others), and End User (Rehabilitation Centers, Hospitals and Clinics, and Home Care)
The Asia Pacific neurorehabilitation devices market was valued at US$ 445.40 million in 2023 and is expected to reach US$ 1,399.71 million by 2031; it is estimated to register a CAGR of 15.4% from 2023 to 2031. Strategic Initiatives by Market Players Boost Asia Pacific Neurorehabilitation Devices Ma ... Read More
-
Europe Liquid Nitrogen Market Forecast to 2031 - Regional Analysis - by Manufacturing Method (Cryogenic Distillation and Pressure Swing Adsorption) and End-use Industry (Aerospace and Defense, Automotive, Chemical, Food and Beverage, Metal Fabrication, Pharmaceutical, Electronics and Semiconductors, and Others)
The Europe liquid nitrogen market was valued at US$ 3,409.70 million in 2023 and is expected to reach US$ 4,962.85 million by 2031; it is estimated to register a CAGR of 4.8% from 2023 to 2031. Rising Demand for Liquid Nitrogen in Food & Beverages Industry Drives Europe Liquid Nitrogen Market The gr ... Read More
-
Asia Pacific Non-Invasive Ventilation Masks Market Forecast to 2031 - Regional Analysis - by Product (Noninvasive Ventilation Disposable Mask and Noninvasive Ventilation Reusable Mask), Application (Sleep Apnea, Chronic Obstructive Pulmonary Disease, Pneumonia, and Others), and End User (Hospitals and Clinics, Home Care, and Others)
The Asia Pacific non-invasive ventilation masks market was valued at US$ 433.81 million in 2023 and is expected to reach US$ 719.68 million by 2031; it is estimated to register a CAGR of 6.5% from 2023 to 2031. Increasing Adoption of NIV Masks Drives Asia Pacific Non-Invasive Ventilation Masks Marke ... Read More
-
Middle East & Africa Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), and End User (Hospitals, Dermatology Centers, and Others)
The Middle East & Africa hyperpigmentation disorder treatment market was valued at US$ 530.30 million in 2022 and is expected to reach US$ 894.55 million by 2030; it is estimated to register a CAGR of 6.8% from 2022 to 2030. Novel Products Based on PATH-3 Technology Bolster Middle East & Africa Hype ... Read More
-
South & Central America Hyperpigmentation Disorder Treatment Market Forecast to 2030 - Regional Analysis - by Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), and End User (Hospitals, Dermatology Centers, and Others)
The South & Central America hyperpigmentation disorder treatment market was valued at US$ 887.76 million in 2022 and is expected to reach US$ 1,484.28 million by 2030; it is estimated to register a CAGR of 6.6% from 2022 to 2030. Rise in Prevalence of Melasma Fuels South & Central America Hyperpigme ... Read More
Research Assistance
